New article: Sustained complete response on crizotinib in primary lung inflammatory myofibroblastic tumor - Case report and literature review https://t.co/mqRKEnqRQy #lungcancer#oncology
Immune Checkpoint Inhibitors in Alveolar Soft Part Sarcoma: New Standard of Care? https://t.co/PzqsiW8ovU
Excellent response to #nivolumab in metasatic #asps. 18 months and still on.. #immunotherapy#sarcoma ..thanks @abhenilmittal
Role of 18F-FDG PET/computed tomography in prognostication... : Nuclear Medicine Communications https://t.co/FSdhCkPJAq @RashiKapoor17@SachinSarcoma@MitalRekha@sorunshishak
Excellent paper from #AIIMS Nuclear Medicine#sarcoma#MPNST#PET CT..Thanks Dr Shamim!
#Neuroendocrine#NET pt support group meeting with @samdoc_mamc yesterday
Few Qs
Q1- How important the grade is?
Q2- Functional vs non functional tumor
Q3- Its so rare that we can't find anyone with whom we can share our experiences
@netpatientfound @CureNETs@netcancerday
Good scientific content for #desmoid#fibromatosis patients and doctors. Role of #tamoxifen really doubtful and in fact there might be some concerning toxicities.
The experience of NETs profoundly changes people’s lives. Fatigue, isolation, worry, and bothersome physical side effects can disrupt daily activities. Here are some simple steps to maintain optimal health and balance during and after cancer care. https://t.co/HFGsPLSmPH
https://t.co/Et1EB9ki8y
Excellent study @samdoc_mamc@RashiKapoor17
This study shows the high level of depression, anxiety and fatigue in patients with #NET
@adarsh1474@CDC_Cancer@sugandhadureja @netpatientfound @drdineshias INET is neuroendocrine support group from India. Please join us so that we can deal with these issues. Rare diseases are very often ignored ..